Yuan‐Soon Ho

China Medical University — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index3.6kcitations73works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nicotinic Acetylcholine Receptors Study(12), Cancer-related Molecular Pathways(9), Cancer, Stress, Anesthesia, and Immune Response(7), Phytochemicals and Antioxidant Activities(5), Cancer Cells and Metastasis(5)

Publications73 total

Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Biomarker Research·2025Open Access
Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of <scp>CHRNA9</scp> and <scp>IGF1R</scp>
The Journal of Pathology·2025· 1 cited
A deep dive into the orchard of health: Exploring the anti-cancer and anti-aging potential of apple polyphenols
Journal of Food and Drug Analysis·2025· 1 citedOpen Access
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Biomarker Research·2025· 3 citedOpen Access
RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect
Molecular Pharmaceutics·2024· 4 citedOpen Access
Investigation of the α9-nicotinic receptor single nucleotide polymorphisms induced oncogenic properties and molecular mechanisms in breast cancer
Human Molecular Genetics·2024· 3 citedOpen Access
P13-15 Investigation of the α9-nicotinic receptor single nucleotide polymorphisms induced oncogenic properties and molecular mechanisms in breast cancer
Toxicology Letters·2024
Apple polyphenol phloretin inhibits type Ⅱ glucose transporter and enhances anti-HER2 antibody drug binding as an adjuvant treatment for HER2-positive breast cancer
Food Science and Human Wellness·2024Open Access
Quercetin inhibits truncated isoform of dopamine- and cAMP-regulated phosphoprotein as adjuvant treatment for trastuzumab therapy resistance in HER2-positive breast cancer
Food Science and Human Wellness·2023· 3 citedOpen Access
StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling.
PubMed·2023· 4 citedOpen Access
The extended concurrent genes signature for disease-free survival in breast cancer
Journal of the Formosan Medical Association·2022· 1 citedOpen Access
Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein
Journal of Food and Drug Analysis·2021· 24 citedOpen Access
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor
Biomaterials Science·2021· 12 citedOpen Access
Inotilone interferes with chromosome replication as an attractive anti-cancer drug target for breast cancer
Annals of Oncology·2019
Additional file 1: of Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells
Figshare·2019Open Access
ISSUE INFORMATION ‐ TOC
Environmental Toxicology·2018Open Access
Long‐term exposure to extremely low‐dose of nicotine and 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK) induce non‐malignant breast epithelial cell transformation through activation of the a9‐nicotinic acetylcholine receptor‐mediated signaling pathway
Environmental Toxicology·2018· 22 cited
DNA primase polypeptide 1 (PRIM1) involves in estrogen‐induced breast cancer formation through activation of the G2/M cell cycle checkpoint
International Journal of Cancer·2018· 59 cited
Abstract 4203: Alpha 9 nicotinic acetylcholine receptor promotes tumor progression in triple negative breast cancer
Cancer Research·2018· 1 cited
The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer
Human Pathology·2018· 25 cited
page 1 of 4Next →

Frequent Co-authors

Chih‐Hsiung Wu(21), Ying‐Jan Wang(13), Shih‐Hsin Tu(13), Li-Ching Chen(13), Po‐Li Wei(9), Yu‐Jia Chang(8), Min‐Hsiung Pan(7), Tzu‐Chun Cheng(7), Chia‐Hwa Lee(6), Shyr‐Yi Lin(6), Jen‐Kun Lin(5), Wen‐Sen Lee(5), How Tseng(5), You-Cheng Liao(5), Rong-Jane Chen(4), Chi‐Tang Ho(4), Jiiang‐Huei Jeng(4), Yu‐Chih Liang(4), Hui‐Wen Chang(4), Chin‐Sheng Hung(4)